Pine Grove Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$810K Buy
677
+64
+10% +$65.4K 0.08% 105
2026
Q1
$564K Buy
613
+14
+2% +$14.2K 0.07% 111
2025
Q4
$644K Buy
+599
New +$573K 0.08% 105

Other funds holding LLY

Pine Grove Financial Group's LLY Position: Q2 2026 in Review

Pine Grove Financial Group increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $65.4K and bringing the position to 677 shares worth $810K. The position accounts for 0.08% of the portfolio, ranked #105.

Pine Grove Financial Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pine Grove Financial Group held 677 shares of Eli Lilly worth $810K as of Q2 2026.
  • Pine Grove Financial Group bought 64 Eli Lilly shares in Q2 2026, an estimated $65.4K.
  • Eli Lilly made up 0.08% of Pine Grove Financial Group's portfolio in Q2 2026, its #105 holding.
  • Pine Grove Financial Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pine Grove Financial Group's 13F filing for Q2 2026, filed 2 Sep 2026.